Christine Cassiano
Chief Corporate Affairs and Brand Strategy Officer
Replay available
Allogene Therapeutics, Inc. (ALLO) Q3 2025 Earnings Call
Allogene Therapeutics, Inc. (NASDAQ: ALLO) Q3 2025 earnings conference call, held 2025-11-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. David Chang
President and Chief Executive Officer
Dr. Zachary Roberts
Executive Vice President of Research and Development and Chief Medical Officer
Jeff Parker
Chief Financial Officer
Salveen Richter
Analyst at Goldman Sachs
Jack Allen
Analyst at Bayer
Sammy Corwin
Analyst at William Blair
Samantha Simical
Analyst at Citi
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Allogene Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.038 Hello, and thank you for standing by. Welcome to Allogene Therapeutics' third quarter 00:00:05.038 -- 00:00:11.186 2025 conference call. At this time, all participants are in listen-only mode. 00:00:11.186 -- 00:00:15.612 After the speaker's presentation, there will be a question and answer session. 00:00:15.612 -- 00:00:20.438 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:20.438 -- 00:00:24.584 You will then hear an automated message advising your hand is raised. 00:00:24.584 -- 00:00:28.718 To withdraw your question, please press star 11 again. 00:00:28.718 -- 00:00:33.681 Please be aware that today's conference call is being recorded. 00:00:33.723 -- 00:00:38.489 I would now like to turn the call over to Christine Cassiano, Chief Corporate Affairs 00:00:38.489 -- 00:00:43.914 and Brand Strategy Officer. Ms. Cassiano, please go ahead. 00:00:43.914 -- 00:00:48.539 Thank you, Operator, and welcome everyone to Allogene's third quarter 2025 conference 00:00:48.539 -- 00:00:53.164 call. After the market closed, Allogene issued a press release that provided a business 00:00:53.164 -- 00:00:56.967 update and financial results for the third quarter of 2025. 00:00:56.967 -- 00:01:00.991 This press release and today's webcast are available on our website. 00:01:00.991 -- 00:01:04.214 Following our prepared remarks, we will host a Q&A session. 00:01:04.214 -- 00:01:08.259 We recognize that historically questions have been multifaceted, but note that we will 00:01:08.259 -- 00:01:11.021 endeavor to keep this call to under an hour. 00:01:11.021 -- 00:01:15.146 I'm joined today by Dr. David Chang, President and Chief Executive Officer, Dr. 00:01:15.146 -- 00:01:19.410 Zachary Roberts, Executive V...